In a report released today, Joseph Catanzaro from Piper Sandler maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a ...

Barclays analyst Peter Lawson assigned a Buy rating to Nurix Therapeutics (NRIX – Research Report) today and set a price target of $31.00. The ...